CRISPR Therapeutics🇨🇭
📈 Listed (CRSP)
Gene EditingZugEst. 2013👤 300 employees📍 CRSP
📊
AMORA SCORE
📊
AMORA Score not yet available
This company is being evaluated across 5 dimensions: Advancement, Mastery, Operations, Reach, and Affinity.
Learn how AMORA Score works →ABOUT
Co-developed Casgevy, first FDA-approved CRISPR therapy (sickle cell disease). Swiss-US biotech.
Pro Intelligence
Unlock full company profile
Access detailed funding data, AMORA scores, technology stack, supply chain position, and customer analysis.
Subscribe Now — $19.9/mo →🔒 Cancel anytime📦 Instant access🌍 500+ analysts trust AMORA
Already subscribed? Sign in to access.
Share this report